The 'Global Furfurylamine (CAS 617-89-0) Market Outlook 2018-2023' offers detailed coverage of furfurylamine industry and presents main market trends. The market research gives historical and forecast market size, demand, end-use details, price trends, and company shares of the leading furfurylamine producers to provide exhaustive coverage of the market for furfurylamine. The report segments the market and forecasts its size, by volume and value, on the basis of application, by products, and by geography.
The report has been prepared based on an in-depth market analysis with inputs from key industry participants. The global furfurylamine market has been segmented into five major regions, namely, North America (U.S., Canada, and others), Europe (U.K., France, Germany, Russia, and others), Asia-Pacific (China, Japan, India, Australia, and others), South America (Brazil, Argentina, and others), and Middle East & Africa (South Africa, Saudi Arabia, and others). Furthermore, the report also includes an in-depth competitive analysis of the key vendors operating in this market.
Key Regions
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- South America
Key Vendors
- Shandong Yuexing Chemical Co., Ltd.
- Pingquan Fengsheng Chemical Co., Ltd.
- Changzhou Huayang Technology Co., Ltd.
- request free sample to get a complete list of companies
Key Questions Answered in This Report
- Analysis of the furfurylamine market including revenues, future growth, market outlook
- Historical data and forecast
- Regional analysis including growth estimates
- Analyzes the end user markets including growth estimates.
- Profiles on furfurylamine including products, sales/revenues, and market position
- Market structure, market drivers and restraints.
Part 1. Summary
Part 2. Report Methodology
2.1 Methodology
2.2 Data Source
Part 3. Market Overview
3.1 General Information
3.2 Product Type
3.3 Application
3.4 Furfurylamine Status & Prospect
Part 4. Industry Value Chain
4.1 Furfurylamine Industry Value Chain Analysis
4.2 Upstream
4.3 End-uses
4.4 Distributors
Part 5. Competitive Landscape
5.1 Global Furfurylamine Sales & Share by Company (2013-2018)
5.2 Global Furfurylamine Revenue & Share by Company (2013-2018)
5.3 Pricing Trends
5.4 Competitive Trends
Part 6. Segmentation by Type
6.1 Global Furfurylamine Sales Volume by Type (2013-2018)
6.2 Global Furfurylamine Revenue by Type (2013-2018)
6.3 Global Furfurylamine Price by Type (2013-2018)
Part 7. Segmentation by Application
7.1 Global Furfurylamine Sales Volume by Application (2013-2018)
7.2 Global Furfurylamine Revenue by Application (2013-2018)
7.3 Global Furfurylamine Price by Application (2013-2018)
Part 8. Regional Perspectives
8.1 Overview
8.2 North America
8.2.1 Market Size (Volume & Value)
8.2.2 by Application
8.2.3 by Country (U.S., Canada, Mexico, etc.)
8.3 Europe
8.3.1 Market Size (Volume & Value)
8.3.2 by Application
8.3.3 by Country (Germany, UK, France, Spain, Italy, etc.)
8.4 Asia-Pacific
8.4.1 Market Size (Volume & Value)
8.4.2 by Application
8.4.3 by Country (China, Japan, Korea, India, etc.)
8.5 Middle East & Africa
8.5.1 Market Size (Volume & Value)
8.5.2 by Application
8.5.3 by Country (Saudi Arabia, Turkey, Nigeria, Iran, South Africa, etc.)
8.6 South America
8.6.1 Market Size (Volume & Value)
8.6.2 by Application
8.6.3 by Country (Brazil, Argentina, Colombia, etc.)
Part 9. Company Profiles
9.1 Company Profile
9.2 Product Offered
9.3 Business Performance
Part 10. Market Forecast
10.1 Global Furfurylamine Market Size Forecast (2018-2023)
10.1.1 Global Furfurylamine Sales Forecast (2018-2023)
10.1.2 Global Furfurylamine Revenue Forecast (2018-2023)
10.2 Forecast by Region
10.2.1 North America
10.2.2 Europe
10.2.3 Asia-Pacific
10.2.4 Middle East & Africa
10.2.5 South America
10.3 Forecast by Type
10.4 Forecast by Application
Part 11. Market Drivers
11.1 Opportunities
11.2 Challenges
11.3 Economic/Political Environmental
Part 12. Industry Activity
12.1 M&As, JVs and Partnership
12.2 Other Developments
Part 13. Appendix
13.1 Glossary
13.2 About Us
13.3 Disclaimer
The global Furfurylamine market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field ...
Furfurylamine is an aromatic amine with formula C5H7NO. It is typically formed by the reductive amination of furfural with ammonia. Furfurylamine is a starting material for pharmaceuticals like furtrethonium, a parasympathomimetic cholinergic. According to latest analysis by Gen Consulting Company, ...
The research team projects that the Furfurylamine market size will grow from XXX in 2020 to XXX by 2027, at an estimated CAGR of XX. The base year considered for the study is 2020, and the market size is projected from 2020 to 2027.
The prime objective of this report is to help the user und...
The research team projects that the 5-[[(2-Aminoethyl)thio]methyl]-N,N-dimethyl-2-furfurylamine CAS 66356-53-4 market size will grow from XXX in 2019 to XXX by 2026, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2026.
...
The research team projects that the Furfurylamine CAS 617-89-0 market size will grow from XXX in 2019 to XXX by 2026, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2026.
The prime objective of this report is to ...
The analysts forecast the global furfurylamine market to exhibit a CAGR of 5.14% during the period 2019-2024. The report covers the present scenario and the growth prospects of the global furfurylamine for 2019-2024. To calculate the market size, the report considers the furfurylamine sales volume a...
The 'Global Furfurylamine (CAS 617-89-0) Market Outlook 2018-2023' offers detailed coverage of furfurylamine industry and presents main market trends. The market research gives historical and forecast market size, demand, end-use details, price trends, and company shares of the leading furfurylamine...